Brazil Sepsis Diagnostics Market Size & Outlook, 2022-2030
Brazil sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Brazil sepsis diagnostics market highlights
- The Brazil sepsis diagnostics market generated a revenue of USD 14.1 million in 2022 and is expected to reach USD 26.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 8% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 14.1 million |
| Market revenue in 2030 | USD 26.1 million |
| Growth rate | 8% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.4% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 21.3 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.01% in 2022. Horizon Databook has segmented the Brazil sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has a significantly high rate of mortality due to sepsis in intensive care units. In addition, as per PLOS, in 2018, the incidence of sepsis in Brazil was high, along with a prevalence of around 50%. According to a study published by Elsevier Espana SLU in July 2024, which included both children and adults, the overall ICU mortality rate for sepsis was 64.5%.
The study also reported a 22.2% mortality rate for hospital-acquired sepsis. In addition, a systematic review and meta-analysis conducted by Tan et al. provided further analysis and context to these mortality rates.
The lack of awareness about the condition aggravated the prevalence in low-income countries. Hence, the high incidence of sepsis and infectious diseases is anticipated to boost demand for relevant diagnostic solutions in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil sepsis diagnostics market size, by product, 2018-2030 (US$M)
Brazil Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
